Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, is pleased to announce the launch of its new microbiome-based over-the-counter (OTC) biomiq skincare range.
Leading the charge in one of the most exciting new areas in skincare, biomiq utilises the skin microbiome to address the underlying causes of certain skin conditions, while helping soothe the skin and restore its natural balance.
Servatus' proprietary clinical program investigating the role of bacteria and microbiome regulation as treatments for certain diseases enabled the Company to apply its scientific knowledge and evidence-based research to the consumer skincare market.
The first product in the biomiq skincare range to be launched is biomiq acne wipes and biomiq acne serum.
